Explanation of Responses:
|
(1)
|
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.
|
(2)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.75 to $247.70, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(3)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.80 to $248.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(4)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.95 to $249.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(5)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $251.00 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(6)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.10 to $252.10 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(7)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.15 to $253.05 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(8)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.30 to $250.20 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(9)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.35 to $251.35 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(10)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.40 to $252.40 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(11)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.45 to $253.25 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(12)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.35 to $252.10 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(13)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.70 to $253.60 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(14)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.75 to $254.75 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|
(15)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.90 to $255.90 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
|